Montreal, Quebec (November 14, 2019) Emovi, Inc., announced today the signing of a multi-year agreement with Kansas City Chiefs offensive guard Laurent Duvernay-Tardif, MDCM, to support the knowledge transfer to health care professionals and patients regarding genealogy with the KneeKG system, a new knee evaluation modality.
Laurent Duvernay-Tardif is one of the best offensive line players in the National Football League (NFL) and a graduate of the Faculty of Medicine at McGill University in Canada. He is the only active player in the NFL who is also a doctor.
In 2017, Laurent Duvernay-Tardif injured his left knee while playing football for the Kansas City Chiefs. Magnetic resonance (MRI) confirmed a sprain in the internal collateral ligament. He was back in the field after four weeks. In 2018, he fractured the fibula with ankle ligament damage and returned to play after 16 weeks. Although his rehabilitation process included physiotherapy sessions, various orthotics and a year of mechanical procedures, he continued to experience knee pain for almost two years. In 2019, Laurent Duvernay-Tardif heard about genealogy with KneeKG.
Laurent Duvernay-Tardif’s genealogy identified biomechanical markers that were a functional consequence of his injuries. The identified mechanical deficits included markers explaining his pain, affecting his performance and leading to a higher risk of injury. The evaluation then produced a more specific rehabilitation and training program to achieve full and painless functionality and optimal performance.
“Thanks to the results of the genealogy, I included in my training program the recommended specific therapeutic program,” said Laurent Duvernay-Tardif. “It was very effective and I’m back in the field without knee pain!”
“Every year, the NFL releases a summary of injuries from the previous season. Knee injuries have been at the top of the list since the early 2000s. “Like many other NFL players, I was part of this statelessness to completely eliminate my pain. When I learned about the innovative approach involving KneeKG and its ability to provide accurate 3D knee assessment in motion and charge, I was immediately intrigued. I wanted this test, “said Laurent Duvernay-Tardif.
KneeKG is the first device in the clinic that allows healthcare professionals to accurately assess patients’ knees in 3D while the patient is in motion and in charge. Contrary to the information provided by X-ray and MRI imaging while the patient is in a static position, KneeKG quickly identifies the functional movement and deficits of the affected knee (s). Just as an electrocardiogram does for the heart, KneeKG genealogy assesses knee function and provides valuable data that allows the physician and other health professionals to understand the problem and determine the most appropriate care. appropriate for the patient to restore optimal knee function.
“The number of knee injuries that NFL players are suffering is alarming and the need for innovation is important. We are delighted that our device has allowed Laurent a return to play without pain in the knee, “said Michelle Laflamme, CEO of Emovi. “We have great respect for Laurent’s achievements as a professional athlete and doctor. We greatly appreciate his support and are honored to collaborate with him and his agent who are a great team! “.
About Emovi Inc.
Emovi, headquartered in Montreal, is a medical device company that develops knee evaluation products to give patients a better quality of life. Emovi has developed KneeKG, a unique clinical tool to assess the symptoms and progression of the pathology in cases of functional knee impairment, in partnership with the university research community of Quebec, including the CHUM Research Center, the School Technology Foundation (ÉTS) and TELUQ. Emovi holds numerous patents and an exclusive worldwide license to market KneeKG.